Profile picture

Professor Wenchao Ou

(China)
Follow
Logo ESC

Contributor content

Phase Ib study of intravenous HRS-9057, an arginine vasopressin V2 receptor antagonist, versus oral tolvaptan in congestive heart failure with volume overload despite prior diuretic therapy
Presentation
Phase Ib study of intravenous HRS-9057, an arginine vasopressin V2 receptor antagonist, versus oral tolvaptan in congestive heart failure with volume overload despite prior diuretic therapy
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources